Fred Alger Management, LLC Abbott Laboratories Transaction History

Fred Alger Management, LLC

$19.8 Billion
Q3 2024

A detailed history of Fred Alger Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Fred Alger Management, LLC holds 43,301 shares of ABT stock, worth $5.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

43,301

Holding current value

$5.1 Million

% of portfolio

0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $4.33 Million - $5.12 Million	43,301 New	43,301 $4.94 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $4.4 Million - $5.31 Million	-43,061 Reduced 99.18%	357 $39,000
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $17 Million - $20.7 Million	-148,698 Reduced 77.4%	43,418 $5.14 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $14.4 Million - $17.6 Million	124,521 Added 184.22%	192,116 $27 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $4.37 Million - $4.84 Million	-37,495 Reduced 35.68%	67,595 $7.99 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $3.46 Million - $4.07 Million	32,717 Added 45.21%	105,090 $12.2 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $3.06 Million - $3.61 Million	-28,139 Reduced 28.0%	72,373 $8.67 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $803,985 - $876,113	-7,657 Reduced 7.08%	100,512 $11 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $1.13 Million - $1.37 Million	12,335 Added 12.87%	108,169 $11.8 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $3.95 Million - $5.05 Million	-51,528 Reduced 34.97%	95,834 $8.76 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $196 Million - $286 Million	-3,117,568 Reduced 95.49%	147,362 $11.6 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $147 Million - $164 Million	-1,875,515 Reduced 36.49%	3,264,930 $284 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $56.8 Million - $61.5 Million	693,474 Added 15.59%	5,140,445 $430 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $82 Million - $95.6 Million	-1,124,616 Reduced 20.18%	4,446,971 $374 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $51.4 Million - $62.1 Million	775,688 Added 16.17%	5,571,587 $445 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $209 Million - $236 Million	3,180,643 Added 196.91%	4,795,899 $347 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $98.2 Million - $118 Million	1,614,243 Added 159352.7%	1,615,256 $118 Million
Q2 2018 Jul 19, 2018	SELL	$57.57 - $63.54 $1.19 Million - $1.31 Million	-20,686 Reduced 95.33%	1,013 $62,000
Q1 2018 May 10, 2018	BUY	$56.27 - $63.62 $1.2 Million - $1.36 Million	21,356 Added 6226.24%	21,699 $1.3 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $18,412 - $19,712	343	343 $20,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account

Fred Alger Management, LLC Abbott Laboratories Transaction History